For the growing population of adults who survived cyanotic congenital heart disease (CCHD) in childhood — thanks to dramatic advances in pediatric cardiac surgery over the past five decades — the medical story doesn't end at discharge. Understanding what happens to their cardiovascular systems decades later is increasingly urgent, as this cohort ages and enters general adult care settings where clinicians may be unprepared for their unique physiology.
This JAMA review synthesizes the pathophysiological mechanisms driving late cardiovascular complications in adult CCHD survivors. Chronic cyanosis — oxygen desaturation resulting from intracardiac or great-vessel mixing of deoxygenated blood — triggers compensatory erythrocytosis, hyperviscosity, and systemic endothelial dysfunction that persist or evolve even after surgical correction. The review details how these adaptations predispose survivors to arrhythmias, heart failure, pulmonary hypertension, thromboembolic events, and accelerated ventricular dysfunction. Specific lesions such as tetralogy of Fallot, transposition of the great arteries, and single-ventricle physiology each carry distinct long-term risk profiles that demand individualized surveillance strategies.
What makes this review particularly clinically valuable is its bridging function: pediatric cardiologists who guided these patients through early life are rarely their adult providers, yet general cardiologists often lack familiarity with the sequelae of repaired cyanotic lesions. The literature on long-term CCHD outcomes has matured substantially, but evidence-based management protocols remain less standardized than for acquired heart disease. Most data still derive from single-center registries and retrospective cohorts rather than large prospective trials, limiting causal inference. Nevertheless, the review's practical guidance on monitoring intervals, anticoagulation considerations, and arrhythmia management reflects the current best evidence. For health-conscious adults with CCHD history or clinicians managing them, the central takeaway is that survival of early surgery marks a beginning, not an endpoint — ongoing specialized cardiac surveillance is essential to healthspan preservation.